	DNA Repair Pathways as Determinants of PARP Inhibitor Resistance and Therapeutic Targets in Cancer. Int J Mol Sci Lavudi K, Renjith MS, Pithana Sai Venkata Vijay C, Kokkanti RR, Pandey P, Ponneganti S. PMID: 43028061 [PubMed - indexed for MEDLINE]
	Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment. Int J Mol Sci Bertalmio N, Marino FAL, Brundu S, Rustichelli S, Giraudo E. PMID: 43028035 [PubMed - indexed for MEDLINE]
	Cancer Risk Linked to Ultra-Processed Foods: Epidemiological Findings, Potential Mechanisms, and Research Outlook. Foods Zhao M, Zhang X. PMID: 43027519 [PubMed]
	The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer. Cancers (Basel) Smith JP. PMID: 43026872 [PubMed]
	Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023. Cancers (Basel) Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y. PMID: 43026856 [PubMed]
	Treatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer. Cancers (Basel) Turner KM, Gurewitz JB, Frakes JM, Denbo JW, Malafa MP, Hodul PJ, Kim DW, Sinnamon AJ. PMID: 43026841 [PubMed]
	Synergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer. Cancers (Basel) Ghosh AK, Jazieh KA, Xie H, Parish MA, Babiker HM, Bekaii-Saab TS, Goenka AH, Knutson KL, Pandey A, Fernandez-Zapico ME, Carr RM, George B. PMID: 43026840 [PubMed]
	Circulating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring. Cancers (Basel) Abue M, Asano N, Morikawa T, Masamune A, Nishizuka S, Yasuda J. PMID: 43026792 [PubMed]
	The Association Between Asthma and Pancreatic Cancer: A Systematic Review. Cancers (Basel) Darawsha B, Lavu H, Yeo CJ, Hanna N, Nevler A. PMID: 43026779 [PubMed]
	Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Pancreatic Neuroendocrine Neoplasms. Cancers (Basel) Jab. PMID: 43026749 [PubMed]
	A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes. HPB (Oxford) Agritelley ES, Kanu EN, Button J, Bao M, Sannareddy DS, Fletcher AA, Skinner H, Molvin A, Rodgman M, Murray S, Chai J, Niedzwiecki D, DeVito NC, Blobe GC, Strickler JH, Hsu SD, Howard M, Abbruzzese JL, Martin AN, Zani S, Lidsky ME, Kim CY, Suhocki P, Cline B, Johnson D, Crosby EJ, Mettu NB, Mastria E, Allen PJ, Nussbaum DP. PMID: 43026127 [PubMed - as supplied by publisher]
	Impact of Clonal Hematopoiesis on Outcomes in Metastatic Pancreatic Ductal Adenocarcinoma: Analysis From the PASS-01 Trial. JCO Precis Oncol Sainamthip P, Somadasan M, Culnane L, Andrews E, Brais L, Andrews M, Jang GH, Zhang A, Wilson JM, Ramotar S, Dodd A, Perez KJ, Yu K, Laheru D, King DA, O'Kane GM, Gallinger S, Tuveson D, Jaffee EM, Knox JJ, Notta F, Aguirre AJ, Wolpin BM, Sperling AS, Singh H. PMID: 43024846 [PubMed - indexed for MEDLINE]
	Pathologic and Molecular Characterization of Branch Duct Intraductal Papillary Mucinous Neoplasm With Advanced Neoplasia Under-Recognized by Kyoto High-Risk Stigmata. Pancreas Maloof T, Chen W, Esnakula AK, Frankel WL, Culp S, Abdelbaki A, Hart PA, Machicado JD, Cruz-Monserrate Z, Shah ZK, Pawlik TM, Krishna SG. PMID: 43024803 [PubMed - as supplied by publisher]
	Tumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open Macarulla T, Picozzi V, Chandana SR, Melichar B, Kasi A, Gang J, Gallego J, de la Fouchardière C, Bullock A, Chunyi H, Wyrwicz L, Osipov A, Dragovich T, Lee W, Feeney K, Philip PA, Ueno M, Van Cutsem E, Seufferlein T, Babiker H, PANOVA-3 study investigators. PMID: 43024239 [PubMed - indexed for MEDLINE]
	Open versus minimally invasive surgery for large type 3 and type 4 gastric cancer: multicentre retrospective national study at high-volume centres. Br J Surg Kitadani J, Tokunaga M, Mizusawa J, Yamamoto K, Fujiya K, Nunobe S, Kinoshita T, Sakashita K, Kasahara K, Ishida M, Hamakawa T, Honda M, Sakuramoto S, Yamada T, Hayata K, Hara K, Tanaka R, Yamagata Y, Kawase T, Kurokawa Y, Boku N, Yoshikawa T. PMID: 43023692 [PubMed - indexed for MEDLINE]
	Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions. Curr Cancer Drug Targets Ma Y, Wang M, Zhang K, Ren F, Wang Y, Zhang W, Kan C, Han F, Sun H, Sun X. PMID: 43023373 [PubMed - as supplied by publisher]
	Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies. Front Immunol Gu G, Du Y, Zhang H, Zheng Y, Yao Y, Yan Q. PMID: 43022561 [PubMed - indexed for MEDLINE]
	Comparison of Survival Between Patients with Hepatocellular Carcinoma Beyond the "Up-to-7" Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: A Target Trial Emulation Study. J Clin Transl Hepatol Su JY, Liu Z, Yang TX, Guo PP, Luo M, Liu SP, Dong XF, Xu XL, Chen SC, Ou JJ, Chen K, Li ZC, Su Z, Yang FQ, He WH, Peng N, Wu PS, Long BB, Su H, Huang ML, Li WT, Chen WT, Li JR, Yang DL, Huang ZH, Lin LP, Huo RR, Ma YL, Ma L, Zhong XB, Zhong JH, GUIDANCE investigators. PMID: 43022106 [PubMed]
	Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar. Ann Surg van Eijck CHJ, Katz MHG, Besselink MG. PMID: 43021448 [PubMed - as supplied by publisher]
	Histopathological findings associated with prognosis in resected ductal adenocarcinoma of the pancreas. Arq Bras Cir Dig Soares EV, Toaza E, Cambruzzi E. PMID: 43017946 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 62185

Page 1 of 3110



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy